Aggarwal Sumit
SEC CIK 1854362 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals, Inc. | Pres, CEO, Dir, 10% | 1.67M | — | — | 6 | 2021-12-01 | 2025-09-19 |
Most active insiders at ELOX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coastlands Capital LP | 10% | — | — |
| 2 | Domicilium Real Estate Fund III LP | 10% | — | — |
| 3 | Walts Alan Edmund | Dir | — | — |
| 4 | Rubin Steven D | Dir | — | — |
Aggarwal Sumit made no open-market trades at ELOX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-08 16:53 | 2025-08-14+ | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Pres, CEO, Dir, 10% | M - OptEx | $0.0855 | +472.8K | 1.67M | +39% | +$40.4K |
| D | 2026-05-08 16:53 | 2025-09-19 | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Pres, CEO, Dir, 10% | A - Grant | $0.00 | +1.00M | 1.40M | +252% | $0 |
| D | 2025-01-28 | 2025-01-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Dir | M - OptEx | $0.00 | +30.0K | 199.9K | +18% | $0 |
| 2024-10-17 | 2024-10-16 | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Pres AND CEO, Dir | A - Grant | $0.00 | +165.0K | 169.9K | +3,347% | $0 | |
| D | 2021-12-03 | 2021-12-01 | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Pres AND CEO, Dir | M - OptEx | $0.00 | +279.2K | 279.2K | New | $0 |
| D | 2021-12-03 | 2021-12-01 | ELOX | Eloxx Pharmaceuticals, Inc. | Aggarwal Sumit | Pres AND CEO, Dir | F - Tax | $0.72 | -81.9K | 197.2K | -29% | -$59.0K |
Purchase Sale Sale after option exercise All abbreviations